Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017
Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and...
Saved in:
Published in | Respiratory research Vol. 21; no. 1; pp. 49 - 13 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
11.02.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.
Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.
The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.
In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. |
---|---|
AbstractList | Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.BACKGROUNDChronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated.Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.METHODSBased on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence.The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.RESULTThe total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI.In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI.CONCLUSIONSIn 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. Keywords: Global, Chronic respiratory diseases, Chronic obstructive pulmonary disease, Asthma, Incidence Abstract Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs have not been estimated. Methods Based on data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we analyzed the prevalence and incidence trends of CRDs from 1990 to 2017 according to age, sex, region and disease pattern. Furthermore, the correlations between the incidence and the World Bank income levels, sociodemographic index (SDI), and human development index (HDI) levels were analyzed to assess the factors affecting incidence. Result The total number of CRD cases increased by 39.5% from 1990 to 2017, nevertheless, the age-standardized prevalence rate (ASPR) and age-standardized incidence rate (ASIR) showed decreasing trends. The ASIRs of CRD, chronic obstructive pulmonary disease (COPD), pneumoconiosis, and asthma decreased, whereas the ASIR of interstitial lung disease and pulmonary sarcoidosis increased during the past 27 years. Significant differences between males and females in the incidence rates of pneumoconiosis, interstitial lung disease and pulmonary sarcoidosis were observed. Elderly people especially suffered from CRDs, except for asthma. For COPD, the ASIR decreased from low-SDI regions to high-SDI regions. The ASIR of interstitial lung disease and pulmonary sarcoidosis in the high-SDI region was highest and have increased mostly. The ASIRs for pneumoconiosis and asthma were inversely related to the HDI. Conclusions In 2017, CRDs were still the leading causes of morbidity worldwide. A large proportion of the disease burden was attributed to asthma and COPD. The incidence rates of all four types of CRDs varied greatly across the world. Statistically significant correlation was found between the ASIR and SDI/HDI. |
ArticleNumber | 49 |
Audience | Academic |
Author | Xie, Min Li, Xiaochen Cao, Xiaopei Liu, Xiansheng Guo, Mingzhou |
Author_xml | – sequence: 1 givenname: Min surname: Xie fullname: Xie, Min – sequence: 2 givenname: Xiansheng surname: Liu fullname: Liu, Xiansheng – sequence: 3 givenname: Xiaopei surname: Cao fullname: Cao, Xiaopei – sequence: 4 givenname: Mingzhou surname: Guo fullname: Guo, Mingzhou – sequence: 5 givenname: Xiaochen orcidid: 0000-0002-2161-6168 surname: Li fullname: Li, Xiaochen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32046720$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1r3DAQhk1JaT7aH9BLMfTSi1ONZUnWpRBCPwKBXrbQm5Cl0UaLLW0lbyD_vnI2TbOhFB0kjZ55hxm9p9VRiAGr6i2Qc4Cef8zQSgoNaUlTTtD0L6oT6DhrpKQ_j56cj6vTnDeEgOgFe1Ud05Z0XLTkpFqtEgabax_qbcJbPWIwWOtgS8R4e3-LrjY3KQZv6oR565OeY7qrrc-oM-bapTjVICWp51i3pcjr6qXTY8Y3D_tZ9ePL59Xlt-b6-9ery4vrxjBO5qa3fKCD7jQbbIstBcLaAajUwLh2tqdCcMvAgpNOoJOWc26FQD5gNwgy0LPqaq9ro96obfKTTncqaq_uAzGtlU6zNyMqyawz0krBCXaUQc94LyQTaDvuqOFF69Nea7sbJrQGw5z0eCB6-BL8jVrHWyUIdAJkEfjwIJDirx3mWU0-GxxHHTDusmop66BrBV3Q98_QTdylUEa1UKKFrpfsL7Uuv6J8cLHUNYuouuDAqeSdhEKd_4Mqy-LkTfGL8yV-kPDuaaOPHf7xRAFgD5gUc07oHhEgavGd2vtOFd-pxXeqLzniWY7xs559XGblx_9k_gZFc9jZ |
CitedBy_id | crossref_primary_10_1007_s00420_023_01991_8 crossref_primary_10_1016_j_intimp_2024_113979 crossref_primary_10_1016_j_lanepe_2021_100122 crossref_primary_10_3389_fmed_2024_1471527 crossref_primary_10_1007_s11095_022_03194_1 crossref_primary_10_1007_s11356_023_27503_2 crossref_primary_10_1371_journal_pcbi_1012680 crossref_primary_10_4103_joa_joa_245_22 crossref_primary_10_3389_fphys_2023_1273645 crossref_primary_10_1177_13591053241272150 crossref_primary_10_2147_COPD_S304527 crossref_primary_10_3389_fpubh_2022_1006536 crossref_primary_10_1002_adbi_202300165 crossref_primary_10_1016_j_ijid_2022_10_013 crossref_primary_10_1109_OJEMB_2024_3360688 crossref_primary_10_1136_bmjresp_2021_000919 crossref_primary_10_7759_cureus_70718 crossref_primary_10_3390_ijms21082765 crossref_primary_10_3390_medicina58060817 crossref_primary_10_3390_medicina57111265 crossref_primary_10_1002_ppul_25849 crossref_primary_10_1039_D3LC00894K crossref_primary_10_1109_TBME_2022_3145688 crossref_primary_10_1007_s10916_025_02154_7 crossref_primary_10_1002_med_21956 crossref_primary_10_1016_j_ajt_2022_11_008 crossref_primary_10_15857_ksep_2024_00115 crossref_primary_10_26724_2079_8334_2023_3_85_31_35 crossref_primary_10_1016_j_heliyon_2023_e19976 crossref_primary_10_1172_JCI150473 crossref_primary_10_1016_j_sleep_2020_07_012 crossref_primary_10_1002_iub_2559 crossref_primary_10_4103_lungindia_lungindia_999_20 crossref_primary_10_1177_14799731251316891 crossref_primary_10_1186_s12890_024_02903_3 crossref_primary_10_1016_j_socscimed_2024_116613 crossref_primary_10_3390_healthcare11152171 crossref_primary_10_1002_ajim_23519 crossref_primary_10_3390_jcm10132889 crossref_primary_10_1109_JTEHM_2022_3193575 crossref_primary_10_1183_23120541_00597_2024 crossref_primary_10_3390_ijerph17165788 crossref_primary_10_60042_2949_2165_2024_2_1_7_24 crossref_primary_10_2139_ssrn_3745183 crossref_primary_10_3389_fmed_2022_1069929 crossref_primary_10_1093_qjmed_hcae010 crossref_primary_10_1186_s12890_022_02059_y crossref_primary_10_1002_adbi_202101139 crossref_primary_10_1186_s12889_025_22193_6 crossref_primary_10_1007_s43450_022_00286_2 crossref_primary_10_1097_CM9_0000000000002855 crossref_primary_10_1002_hsr2_575 crossref_primary_10_1136_bmjresp_2023_002103 crossref_primary_10_1007_s13721_023_00419_0 crossref_primary_10_1177_14799731241233301 crossref_primary_10_1177_1357633X20970402 crossref_primary_10_1007_s00210_023_02830_w crossref_primary_10_1016_j_jddst_2022_103659 crossref_primary_10_1186_s12889_025_22272_8 crossref_primary_10_1016_j_mayocp_2022_09_007 crossref_primary_10_1016_j_resp_2024_104368 crossref_primary_10_1186_s12889_023_15553_7 crossref_primary_10_1016_j_pulmoe_2022_07_007 crossref_primary_10_7759_cureus_49230 crossref_primary_10_18273_revmed_v36n1_2023001 crossref_primary_10_3390_geriatrics9020034 crossref_primary_10_1007_s00484_023_02504_5 crossref_primary_10_1007_s11356_022_23094_6 crossref_primary_10_1136_thoraxjnl_2020_216732 crossref_primary_10_29413_ABS_2023_8_3_22 crossref_primary_10_1152_ajplung_00207_2020 crossref_primary_10_2147_PPA_S417375 crossref_primary_10_3390_biomedicines12030488 crossref_primary_10_36290_csf_2020_025 crossref_primary_10_3390_jcm11164864 crossref_primary_10_1016_j_fbio_2024_105201 crossref_primary_10_1016_j_horiz_2023_100078 crossref_primary_10_1109_TCSII_2020_3046919 crossref_primary_10_3390_nu13114055 crossref_primary_10_3390_cells10123437 crossref_primary_10_1016_j_ejphar_2024_176846 crossref_primary_10_1208_s12249_024_02776_z crossref_primary_10_1080_10408398_2021_1915744 crossref_primary_10_1080_23748834_2022_2094884 crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_25_22 crossref_primary_10_1186_s12931_023_02353_1 crossref_primary_10_3389_fphys_2020_613398 crossref_primary_10_1016_j_it_2024_06_005 crossref_primary_10_1016_j_jddst_2024_105381 crossref_primary_10_1152_ajplung_00103_2021 crossref_primary_10_1016_j_pce_2022_103232 crossref_primary_10_3390_antiox12061140 crossref_primary_10_1016_j_hjc_2022_10_004 crossref_primary_10_1016_j_hermed_2023_100685 crossref_primary_10_1186_s12890_021_01745_7 crossref_primary_10_1007_s10517_022_05566_4 crossref_primary_10_4103_mtsm_mtsm_15_23 crossref_primary_10_4046_trd_2023_0100 crossref_primary_10_1186_s12889_020_10042_7 crossref_primary_10_1186_s12913_023_10525_4 crossref_primary_10_18632_aging_204358 crossref_primary_10_1080_09638288_2023_2233899 crossref_primary_10_2217_nnm_2021_0437 crossref_primary_10_3389_fcell_2023_1149499 crossref_primary_10_1016_j_ecoenv_2024_116740 crossref_primary_10_1016_j_opresp_2023_100245 crossref_primary_10_1016_j_heliyon_2023_e19596 crossref_primary_10_1016_j_jnutbio_2021_108632 crossref_primary_10_1136_bmjopen_2023_083795 crossref_primary_10_4103_ecdt_ecdt_5_22 crossref_primary_10_21053_ceo_2021_02054 crossref_primary_10_3390_ijms24129913 crossref_primary_10_2174_1381612826999201116161143 crossref_primary_10_1186_s12931_022_02045_2 crossref_primary_10_1007_s10654_020_00626_3 crossref_primary_10_35627_2219_5238_2023_31_11_66_73 crossref_primary_10_2147_JIR_S324323 crossref_primary_10_1080_17476348_2022_2149496 crossref_primary_10_1177_00469580231214469 crossref_primary_10_1186_s12890_022_02040_9 crossref_primary_10_56294_mw2024496 |
Cites_doi | 10.5603/ARM.2017.0016 10.1016/j.envint.2018.06.016 10.1016/j.jhep.2018.12.001 10.1016/S0140-6736(07)61696-1 10.1016/S0140-6736(15)60264-1 10.1001/jama.2013.284692 10.3399/bjgp18X699389 10.5588/ijtld.14.0446 10.1186/1465-9921-8-89 10.3390/ijerph14080841 10.1183/09059180.00009113 10.1093/eurpub/ckx109 10.2147/COPD.S147628 10.1080/08870446.2017.1325890 10.1111/crj.12028 10.1016/j.chest.2016.08.1474 10.1016/S2213-2600(14)70008-6 10.1055/s-0037-1603766 10.1016/j.envint.2019.04.026 10.1183/13993003.00559-2017 10.21037/jtd.2017.11.91 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2020 |
DBID | AAYXX CITATION NPM 3V. 7QL 7U7 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12931-020-1291-8 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics |
EISSN | 1465-993X |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_95dfc9d9760e435185687957ed46f3c6 PMC7014719 A616396491 32046720 10_1186_s12931_020_1291_8 |
Genre | Journal Article |
GeographicLocations | China Singapore |
GeographicLocations_xml | – name: China – name: Singapore |
GrantInformation_xml | – fundername: Key Technologies Research and Development Program grantid: 2016YFC1304500 – fundername: Young Scientists Fund grantid: 81700052 – fundername: Natural Science Foundation of China grantid: 81670020 – fundername: ; grantid: 81670020 – fundername: ; grantid: 81700052 – fundername: ; grantid: 2016YFC1304500 |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 FRP M~E NPM PMFND 7QL 7U7 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c560t-8d6b3ba4a5bd2e231052b139a156afd83776d51d1f9f7ef9d666d77e6be4b70b3 |
IEDL.DBID | M48 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Wed Aug 27 01:29:26 EDT 2025 Thu Aug 21 18:33:16 EDT 2025 Fri Jul 11 11:43:01 EDT 2025 Sat Aug 23 14:58:15 EDT 2025 Tue Jun 17 21:50:45 EDT 2025 Tue Jun 10 20:48:59 EDT 2025 Thu Jan 02 23:00:43 EST 2025 Thu Apr 24 23:00:59 EDT 2025 Tue Jul 01 02:43:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Chronic obstructive pulmonary disease Chronic respiratory diseases Global Asthma Incidence |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-8d6b3ba4a5bd2e231052b139a156afd83776d51d1f9f7ef9d666d77e6be4b70b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2161-6168 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12931-020-1291-8 |
PMID | 32046720 |
PQID | 2357214895 |
PQPubID | 42864 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_95dfc9d9760e435185687957ed46f3c6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7014719 proquest_miscellaneous_2354142739 proquest_journals_2357214895 gale_infotracmisc_A616396491 gale_infotracacademiconefile_A616396491 pubmed_primary_32046720 crossref_primary_10_1186_s12931_020_1291_8 crossref_citationtrail_10_1186_s12931_020_1291_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-02-11 |
PublicationDateYYYYMMDD | 2020-02-11 |
PublicationDate_xml | – month: 02 year: 2020 text: 2020-02-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Respiratory research |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | A Descatha (1291_CR13) 2018; 119 L Nathell (1291_CR22) 2007; 8 DO Abegunde (1291_CR7) 2007; 370 F Nissen (1291_CR25) 2018; 68 RC Jones (1291_CR23) 2014; 2 Coralynn Sack (1291_CR16) 2017; 50 M Ng (1291_CR18) 2014; 311 V Bilano (1291_CR20) 2015; 385 1291_CR6 E Stafyla (1291_CR24) 2018; 13 N Khaltaev (1291_CR1) 2017; 9 P Burney (1291_CR9) 2015; 19 1291_CR11 1291_CR10 KM Antoniou (1291_CR15) 2014; 23 S Prazakova (1291_CR14) 2014; 8 S Sahni (1291_CR8) 2017; 85 1291_CR2 R West (1291_CR19) 2017; 32 1291_CR4 P Yin (1291_CR5) 2016; 150 G Ferrante (1291_CR3) 2017; 27 M Bonifazi (1291_CR17) 2017; 38 Z Liu (1291_CR12) 2019; 70 J Li (1291_CR21) 2019; 128 |
References_xml | – volume: 85 start-page: 97 year: 2017 ident: 1291_CR8 publication-title: Adv Respir Med doi: 10.5603/ARM.2017.0016 – volume: 119 start-page: 366 year: 2018 ident: 1291_CR13 publication-title: Environ Int doi: 10.1016/j.envint.2018.06.016 – volume: 70 start-page: 674 year: 2019 ident: 1291_CR12 publication-title: J Hepatol doi: 10.1016/j.jhep.2018.12.001 – volume: 370 start-page: 1929 year: 2007 ident: 1291_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(07)61696-1 – volume: 385 start-page: 966 year: 2015 ident: 1291_CR20 publication-title: Lancet doi: 10.1016/S0140-6736(15)60264-1 – volume: 311 start-page: 183 year: 2014 ident: 1291_CR18 publication-title: JAMA doi: 10.1001/jama.2013.284692 – ident: 1291_CR10 – ident: 1291_CR6 – volume: 68 start-page: e775 year: 2018 ident: 1291_CR25 publication-title: Br J Gen Pract doi: 10.3399/bjgp18X699389 – volume: 19 start-page: 10 year: 2015 ident: 1291_CR9 publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.14.0446 – volume: 8 start-page: 89 year: 2007 ident: 1291_CR22 publication-title: Respir Res doi: 10.1186/1465-9921-8-89 – ident: 1291_CR4 doi: 10.3390/ijerph14080841 – volume: 23 start-page: 40 year: 2014 ident: 1291_CR15 publication-title: Eur Respir Rev doi: 10.1183/09059180.00009113 – volume: 27 start-page: 1110 year: 2017 ident: 1291_CR3 publication-title: Eur J Pub Health doi: 10.1093/eurpub/ckx109 – volume: 13 start-page: 487 year: 2018 ident: 1291_CR24 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S147628 – volume: 32 start-page: 1018 year: 2017 ident: 1291_CR19 publication-title: Psychol Health doi: 10.1080/08870446.2017.1325890 – volume: 8 start-page: 1 year: 2014 ident: 1291_CR14 publication-title: Clin Respir J doi: 10.1111/crj.12028 – volume: 150 start-page: 1269 year: 2016 ident: 1291_CR5 publication-title: Chest doi: 10.1016/j.chest.2016.08.1474 – volume: 2 start-page: 267 year: 2014 ident: 1291_CR23 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(14)70008-6 – volume: 38 start-page: 437 year: 2017 ident: 1291_CR17 publication-title: Semin Respir Crit Care Med doi: 10.1055/s-0037-1603766 – volume: 128 start-page: 46 year: 2019 ident: 1291_CR21 publication-title: Environ Int doi: 10.1016/j.envint.2019.04.026 – ident: 1291_CR11 – ident: 1291_CR2 – volume: 50 start-page: 1700559 issue: 6 year: 2017 ident: 1291_CR16 publication-title: European Respiratory Journal doi: 10.1183/13993003.00559-2017 – volume: 9 start-page: 4676 year: 2017 ident: 1291_CR1 publication-title: J Thorac Dis doi: 10.21037/jtd.2017.11.91 |
SSID | ssj0017875 |
Score | 2.5965233 |
Snippet | Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence of CRDs... Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and incidence... Abstract Background Chronic respiratory diseases (CRDs) are leading causes of morbidity worldwide. However, the spatial and temporal trends in prevalence and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 49 |
SubjectTerms | Age Asthma Chronic diseases Chronic illnesses Chronic obstructive pulmonary disease Chronic respiratory diseases Datasets Generalized linear models Geriatrics Global Incidence Injury analysis Lung diseases Males Morbidity Obstructive lung disease Older people Pneumoconiosis Respiratory diseases Respiratory tract diseases Risk analysis Risk factors Sarcoidosis Sexes Silicosis Socioeconomic factors Statistical analysis Statistics Trends World health |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9RAEB6kD9IXUdvaaC0rCEIhNJv9lX2sYilCfWqhb0v2FxYkV-6u_39nkr3zgmBffL3dQHYyk2--m8k3AJ9VCJ3xUtUi6lhLmXXd25xqxIIutEJHkYgoXv_UV7fyx5262xn1RT1hkzzwZLhzq2IONiJqNgmhHeFF03xsk6LUWYRRbBsxb0OmSv0A3VCVGibv9PmKUA1pc0udCJbX3QyFRrH-v1_JO5g075fcAaDL1_CqZI7sYrrjN_AiDW_h5XWpjR_AzdTeyu4H9rAkEW-KWdYPkdHf6ePoULbILExquGz5p8bOSpVmxehjE8YROth6wRC0zSHcXn6_-XZVl5kJdcDcZV13UXvhe9krH9tEyZtqPWZ5PfK0Pkeko0ZHxSPPNpuUbUT6Eo1J2ifpTePFEewNiyEdA4sJcwWhUqK0DpHeIhdEgihkRxo4RlXQbGzoQhEUp7kWv91ILDrtJrM7NLsjs7uugrPtJQ-Tmsa_Nn-lB7PdSELY4w_oHq64h3vOPSr4Qo_VUbjizYW-fHWARyThK3ehMSG1WlpewclsJ4ZZmC9vHMOVMF850gpqkVBaNMan7TJdSa1rQ1o8jnskl2gxW8G7yY-2RxJtg0DVNhWYmYfNzjxfGe5_jSLgBrmt4fb9_zDSB9hvKTZozg0_gb318jF9xFxr7U_HsHoCZqwgvw priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpe86SYsKhUJBxLL1sE4lLQ2hkJ4S2JuwHm4Dxd7ubv5_Z2ytE1PI1ZLAkmY032hG3wB8VCE0xkvF66gjl7LTvLVd4mgLmlDVOtaJHMWLn_r8Sv5YqVW-cNvmtMr9mTge1HEIdEd-QrQsFWJ3q76s_3KqGkXR1VxC4yE8Iuoykmqzmh0ugcKoptdFiltbiRzVFI0-2ZKdQ0e6otwEK3izsEsjff__h_QdK7XMoLxjks6ewdOMJdnptPnP4UHqX8DjixwtfwmXU8Iru-7ZekO03qTFrO0jowv2sZgoGzoWJn5ctrmNurMct9kyen7CBBoTthsYmnHzCq7Ovl9-O-e5igIPiGZ2vIna176VrfKxSgTnVOUR97XoubVdRAfV6KhEFJ3tTOpsRIcmGpO0T9Kb0tev4aAf-vQWWEyIHmqVEgE9tP0WvUN0GWvZECuOUQWU-zV0IVOMU6WLP250NRrtpmV3uOyOlt01BXyeh6wnfo37On-ljZk7EjX2-GHY_HJZ05xVsQs2IswqE2JBxCOaCqqbFKXu6qAL-ETb6kiB8edCm98h4BSJCsudaoSoVksrCjhe9ETFC8vmvWC4rPhbdyumBXyYm2kkJbP1abgZ-0ghccVsAW8mOZqnVFclmq6qLMAsJGwx52VLf_17pAU36O0aYQ_v_60jeFKR1FNNG3EMB7vNTXqHuGrn34_K8w9m1xrg priority: 102 providerName: ProQuest |
Title | Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32046720 https://www.proquest.com/docview/2357214895 https://www.proquest.com/docview/2354142739 https://pubmed.ncbi.nlm.nih.gov/PMC7014719 https://doaj.org/article/95dfc9d9760e435185687957ed46f3c6 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3batwwEB1ygZKX0qY3p-miQqFQcOuLLtZDCJuSEBY2lDYL-yZsSU4DwU69G0j-PjO2dxPTkCfDSjaWZmbnHEs6A_BFWJupgoswddKFnJcyzHXpQ8wFmU1S6VJPRHF6Jk9nfDIX8w1YlbfqJ3DxJLWjelKz5ur77b-7Qwz4gzbgM_ljQTkLSXFC-wx0HGabsI2JSVFBgyl_WFRA3xTdYSMRap3E_SLnk48YpKlWzf___-xHSWu4ofJRhjp5BS97aMnGnS-8hg1f7cKLab94vgs7BCw7XeY3cN5thmWXFbtuSPKbIpzllWP08b0tNMrqktlOO5c1DyvyrF_TWTA6msJiTDRsWTNM8eotzE6Oz3-ehn2FhdAi0lmGmZNFWuQ8F4VLPEE9kRSICXNkdXnpkLwq6UTs4lKXypfaIdlxSnlZeF6oqEjfwVZVV_4DMOcRWaTCewKBiAs0MkekkynPSDFHiQCi1YQa28uPUxWMK9PSkEyazgYGbWDIBiYL4Nv6lutOe-O5zkdkpXVHks1uf6ibC9NHodHClVY7hGCRR5yIWEVSsXXlHZdlamUAX8nGhtwNX87m_RkFHCLJZJmxRPiqJddxAPuDnhiUdti88hKz8mlDykIJ0k-Nk_F53Ux30ka3ytc3bR8ec5wxHcD7zqnWQ0qTCNNaEgWgBu42GPOwpbr820qGK2TCKtZ7z7_1R9hJKASo3k28D1vL5sZ_Qsy1LEawqeZqBNvj8eTPBK9Hx2e_fo_aLxijNsruAb4qJtA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMEChgJhIQUNXb8iA8IlUe1pd2ettLeTBI7UAkly-5WiD_Fb2QmyaaNkHrrde2s4vGM5_sy4xmA16osM1NIFade-1jKSse5rUKMviArRap9GogoTk_05FR-nav5Fvzd3IWhtMrNmdge1L4p6Rv5HpVlEYjdrfqw-BVT1yiKrm5aaHRqcRT-_EbKtnp_-Bn3940QB19mnyZx31UgLtG7r-PM6yItcpmrwotA8EaJAnFQjkwmrzwSNqO94p5XtjKhsh4Bvjcm6CLIwiRFiv97A26i402I7Jn5QPA4Kr_qbjOp2FrB-ygqz_TeivwqEndBuRCWx9nID7btAv53Cpe84jhj85ILPLgHd3vsyvY7ZbsPW6F-ALemfXT-Icy6BFt2VrPFksqI06nB8toz-qDfNi9lTcXKrh4vW15E-VkfJ1oxuu7CODovtm4YwgbzCE6vRb6PYbtu6vAEmA-IVlIVAgFLxBoW2ShS1FRmVIXHqAiSjQxd2Zc0p84aP11LbTLtOrE7FLsjsbssgnfDI4uunsdVkz_SxgwTqRR3-0Oz_O56y3ZW-aq0HmFdEhB7Iv7R1MDdBC91lZY6gre0rY4ODHy5Mu_vPeASqfSW29cIia2WlkewO5qJhl6OhzeK4fqDZuUuzCKCV8MwPUnJc3Vozts5kkuUmI1gp9OjYUmpSNBViiQCM9Kw0ZrHI_XZj7YMuUF2bbh9evVrvYTbk9n02B0fnhw9gzuCLID66fBd2F4vz8NzxHTr4kVrSAy-Xbfl_gOialhL |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+prevalence+and+incidence+of+chronic+respiratory+diseases+from+1990+to+2017&rft.jtitle=Respiratory+research&rft.au=Xie%2C+Min&rft.au=Liu%2C+Xiansheng&rft.au=Cao%2C+Xiaopei&rft.au=Guo%2C+Mingzhou&rft.date=2020-02-11&rft.pub=BioMed+Central+Ltd&rft.issn=1465-9921&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12931-020-1291-8&rft.externalDocID=A616396491 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |